相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
James F. Howard et al.
NEUROLOGY (2019)
Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim
Hanny Al-Samkari et al.
ANNALS OF HEMATOLOGY (2019)
M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study
Leona E. Ling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
James Bussel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
Peter Ulrichts et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
Peter Kiessling et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Anne Zufferey et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Clinical relevance of antiplatelet antibodies and the hepatic clearance of platelets in patients with immune thrombocytopenia
Silvia Cantoni et al.
BLOOD (2016)
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis
Indraraj Umesh Doobaree et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk
Rutger A. Middelburg et al.
HEMATOLOGY (2016)
Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies
Nora P. Goette et al.
PLOS ONE (2016)
Fatigue in immune thrombocytopenia
Quentin A. Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
June Li et al.
NATURE COMMUNICATIONS (2015)
Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics
Kine Marita Knudsen Sand et al.
FRONTIERS IN IMMUNOLOGY (2015)
Laboratory testing for platelet antibodies
Nahla M. Heikal et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
Francesco Rodeghiero et al.
BLOOD (2013)
Immune Thrombocytopenia
Gaurav Kistangari et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis
Dilip K. Challa et al.
MABS (2013)
Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)
Abderrahim Najaoui et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Immune Thrombocytopenia: Pathophysiologic and Clinical Update
Roberto Stasi
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP)
Ameet Sarpatwari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database
Ameet Sarpatwari et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production
Diane Nugent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Antiplatelet Antibodies in Chronic Immune Thrombocytopenia and Their Role in Platelet Destruction and Defective Platelet Production
Robert McMillan
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Serum Immunoglobulins and Risk of Infection: How Low Can You Go?
Daniel E. Furst
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura
Robert McMillan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey
Claire F. Snyder et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective
Susan D. Mathias et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2008)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
C Vaccaro et al.
NATURE BIOTECHNOLOGY (2005)
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
R McMillan et al.
BLOOD (2004)
Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura
EJ Houwerzijl et al.
BLOOD (2004)
A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura
KE Webert et al.
BLOOD (2003)
Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro
M Chang et al.
BLOOD (2003)
Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: Assays and epitopes
R McMillan
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Medical progress: Immune thrombocytopenic purpura.
DB Cines et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts
YC Cohen et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
